Article Information
History
- December 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Katheryn A.Q. Cousins, PhD1,*,
- David J. Irwin, MD1,
- Alice Chen-Plotkin, MD1,
- Leslie M. Shaw, PhD2,
- Sanaz Arezoumandan, MD1,
- Edward B. Lee, MD, PhD2,
- David A. Wolk, MD1,
- Daniel Weintraub, MD3,
- Meredith Spindler, MD1,
- Andres Deik, MD1,
- Murray Grossman, MDCM, EdD1 and
- Thomas F. Tropea, DO1
- 1Department of Neurology, Perelman School of Medicine, University of Pennsylvania
- 2Department of Pathology and Laboratory Medicine, University of Pennsylvania
- 3Department of Psychiatry, University of Pennsylvania
- ↵*Correspondence should be addressed to: Katheryn Cousins, Penn Frontotemporal Degeneration Center, Department of Neurology, Richards Medical Research Laboratories, Suite 600B, 3700 Hamilton Walk, Philadelphia, PA 19104, katheryn.cousins{at}pennmedicine.upenn.edu
Posted December 06, 2022.
Plasma GFAP associates with secondary Alzheimer’s pathology in Lewy body disease
